A
Arthur J. Moss
Researcher at University of Rochester Medical Center
Publications - 681
Citations - 79063
Arthur J. Moss is an academic researcher from University of Rochester Medical Center. The author has contributed to research in topics: Heart failure & Cardiac resynchronization therapy. The author has an hindex of 107, co-authored 681 publications receiving 74898 citations. Previous affiliations of Arthur J. Moss include Rochester General Health System & Bikur Cholim Hospital.
Papers
More filters
Journal ArticleDOI
Therapeutic uses of permanent pervenous atrial pacemakers: A review.
TL;DR: The available techniques for permanent pervenous atrial pacing have been reviewed with particular emphasis on the coronary vein approach, which involves the use of bifocal atrioventricular sequential pacing, pairedAtrial pacing, and rapid atrial paced generators.
Journal ArticleDOI
Left Atrial Volume and the Benefit of Cardiac Resynchronization Therapy in the MADIT-CRT Trial
Rafael Kuperstein,Ilan Goldenberg,Arthur J. Moss,Scott D. Solomon,Mikhail Bourgoun,Amil M. Shah,Scott McNitt,Wojciech Zareba,Robert Klempfner +8 more
TL;DR: LAV is an independent correlate of clinical outcomes in mildly symptomatic HF patients treated with CRT-D and can be used for improved risk assessment in this population of patients.
Journal ArticleDOI
MADIT-II: substudies and their implications.
TL;DR: In MADIT-II, prophylactic ICD therapy was effective in improving survival in patients with prior myocardial infarction and an ejection fraction
Journal ArticleDOI
Clinical impact, safety, and efficacy of single- versus dual-coil ICD leads in MADIT-CRT.
Valentina Kutyifa,Valentina Kutyifa,Anne-Christine Ruwald,Mehmet K. Aktas,Christian Jons,Scott McNitt,Bronislava Polonsky,László Gellér,Béla Merkely,Arthur J. Moss,Wojciech Zareba,Poul Erik Bloch Thomsen +11 more
TL;DR: Current data on efficacy, safety and impact on clinical outcome of single‐ versus dual‐coil implantable cardioverter‐defibrillator (ICD) leads are limited and contradictory.
Journal ArticleDOI
Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction
N. K. Kaba,Charles W. Francis,Arthur J. Moss,Wojciech Zareba,David Oakes,K. L. Knox,Isabel Diana Fernandez,David L. Rainwater +7 more
TL;DR: There are significant associations of lipid profiles with hemostatic factors, the directions of which suggest novel pathways by which dyslipidemia may contribute to coronary heart disease.